J.Safra Asset Management Corp Veracyte, Inc. Transaction History
J.Safra Asset Management Corp
- $1.31 Billion
- Q2 2025
A detailed history of J.Safra Asset Management Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, J.Safra Asset Management Corp holds 18 shares of VCYT stock, worth $450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 8
125.0%
Holding current value
$450
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
302Shares Held
79.2MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$195 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$131 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$98.6 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$96.4 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.79B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...